HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R ...

Poster Presentation Details : Presenter: Iredell Iglehart, M.D. Title: Advancing Fibromyalgia Treatment: Transmucosal Sublingual Cyclobenzaprine (TNX-102 SL1) Targets Non-restorative Sleep and ...

Environmental Studies Thesis Poster Presentation. All Environmental Studies majors participate in public poster presentations as part of the thesis process. A poster session is organized for Wednesday ...

On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation at the Society for Investigative Dermatology (SID) Annual Meeting. The poster entitled “Immunomodulatory ...

CHICAGO, May 15, 2025--MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today ...

Poster Presentation: Comparison of Demographics and Clinical Characteristics using Real World Data from Tempus Multimodal Database and SEER Cancer Registry Across 17 Solid Cancer Cohorts Date/Time ...

CHICAGO — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one ...

Presentation 3: Finding a Use Case: Data Analysis and Visualization: Anish Tokas, Psychology . Presentation 4: Using An AI Tutor in PSY 101 - Assessment Benchmarking, and Developing a Wellness Focused ...

Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been accepted for the 28th Annual ...

Details on the poster presentation are below: Presentation Title: Multabodies: A next-generation approach for cancer immunotherapy and 4-1BB agonist therapy Abstract Number: 2889/28 Session Date ...

TORONTO & PHILADELPHIA — Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for patients facing ...